DE602007006966D1 - Pyrazoloä1,5-aüpyrimidine, verfahren, anwendungen und zusammensetzungen - Google Patents

Pyrazoloä1,5-aüpyrimidine, verfahren, anwendungen und zusammensetzungen

Info

Publication number
DE602007006966D1
DE602007006966D1 DE602007006966T DE602007006966T DE602007006966D1 DE 602007006966 D1 DE602007006966 D1 DE 602007006966D1 DE 602007006966 T DE602007006966 T DE 602007006966T DE 602007006966 T DE602007006966 T DE 602007006966T DE 602007006966 D1 DE602007006966 D1 DE 602007006966D1
Authority
DE
Germany
Prior art keywords
pyrazoloe1
atpyrimidines
compositions
applications
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007006966T
Other languages
English (en)
Inventor
Luis Anglada
Albert Palomer
Antonio Guglietta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Publication of DE602007006966D1 publication Critical patent/DE602007006966D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE602007006966T 2006-08-04 2007-08-02 Pyrazoloä1,5-aüpyrimidine, verfahren, anwendungen und zusammensetzungen Active DE602007006966D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83544406P 2006-08-04 2006-08-04
EP06118454A EP1884516A1 (de) 2006-08-04 2006-08-04 Pyrazolo[1,5-a]pyrimidine, diese enthaltende pharmazeutische Zubereitungen und ihre Verwendung
PCT/EP2007/058006 WO2008015253A1 (en) 2006-08-04 2007-08-02 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions

Publications (1)

Publication Number Publication Date
DE602007006966D1 true DE602007006966D1 (de) 2010-07-15

Family

ID=37864479

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007006966T Active DE602007006966D1 (de) 2006-08-04 2007-08-02 Pyrazoloä1,5-aüpyrimidine, verfahren, anwendungen und zusammensetzungen

Country Status (25)

Country Link
US (1) US8158632B2 (de)
EP (2) EP1884516A1 (de)
JP (1) JP2009545568A (de)
KR (1) KR20090046916A (de)
CN (1) CN101641359A (de)
AR (1) AR062205A1 (de)
AT (1) ATE469906T1 (de)
AU (1) AU2007280412A1 (de)
BR (1) BRPI0715169A2 (de)
CA (1) CA2659969A1 (de)
CL (1) CL2007002262A1 (de)
CY (1) CY1110757T1 (de)
DE (1) DE602007006966D1 (de)
DK (1) DK2059521T3 (de)
ES (1) ES2346810T3 (de)
HK (1) HK1129105A1 (de)
MX (1) MX2009001149A (de)
NO (1) NO20090972L (de)
PL (1) PL2059521T3 (de)
PT (1) PT2059521E (de)
RU (1) RU2458063C2 (de)
SI (1) SI2059521T1 (de)
TW (1) TW200815445A (de)
UY (1) UY30521A1 (de)
WO (1) WO2008015253A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095742A1 (en) 2008-01-31 2009-08-06 Cellectis New i-crei derived single-chain meganuclease and uses thereof
WO2010053127A1 (ja) * 2008-11-05 2010-05-14 協和発酵キリン株式会社 α1GABAA受容体またはα5GABAA受容体の調整剤
MX2012009866A (es) * 2010-02-26 2012-09-12 Mitsubishi Tanabe Pharma Corp Compuestos pirazolopirimidina y su uso como inhibidores de fosfodiesterasa 10.
CN102807569B (zh) * 2012-08-21 2015-02-25 四川大学 一种镇静催眠的化合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US4847256A (en) * 1986-10-16 1989-07-11 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidines
EP0521622B1 (de) * 1991-07-03 1997-08-13 PHARMACIA & UPJOHN COMPANY Pyrazolopyrimiden- und Pyrimidinylbisphosphonsäureester als entzündungshemmende Mittel
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
TWI252851B (en) * 2003-07-24 2006-04-11 Ferrer Int 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
EP1736475A1 (de) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenierte Pyrazolo[1,5-a]pyrimidine, Verfahrene, Verwendung und Zwischenprodukte
DE102005028765B4 (de) * 2005-06-22 2016-01-21 Airbus Operations Gmbh Verfahren zur Herstellung eines Verstärkungsprofils
EP1956021A1 (de) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Verfahren zur Herstellung von Crystallin pyrazol[1,5-a]pyrimidin Verbindung

Also Published As

Publication number Publication date
US8158632B2 (en) 2012-04-17
HK1129105A1 (en) 2009-11-20
UY30521A1 (es) 2008-02-29
WO2008015253A1 (en) 2008-02-07
CA2659969A1 (en) 2008-02-07
DK2059521T3 (da) 2010-09-27
NO20090972L (no) 2009-04-30
RU2458063C2 (ru) 2012-08-10
ATE469906T1 (de) 2010-06-15
AU2007280412A1 (en) 2008-02-07
BRPI0715169A2 (pt) 2013-06-11
EP1884516A1 (de) 2008-02-06
ES2346810T3 (es) 2010-10-20
JP2009545568A (ja) 2009-12-24
MX2009001149A (es) 2009-03-02
CL2007002262A1 (es) 2008-01-18
PT2059521E (pt) 2010-08-26
EP2059521B1 (de) 2010-06-02
PL2059521T3 (pl) 2010-11-30
KR20090046916A (ko) 2009-05-11
CY1110757T1 (el) 2015-06-10
CN101641359A (zh) 2010-02-03
RU2009107734A (ru) 2010-09-10
TW200815445A (en) 2008-04-01
US20090264448A1 (en) 2009-10-22
EP2059521A1 (de) 2009-05-20
AR062205A1 (es) 2008-10-22
SI2059521T1 (sl) 2010-09-30

Similar Documents

Publication Publication Date Title
DE602007013436D1 (de) N-methylaminomethyl-isoindol-verbindungen und diese enthaltende zusammensetzungen und diese verwendende verfahren
ATE469940T1 (de) Polyethylenzusammensetzungen, herstellungsverfahren dafür und gegenstände daraus
DK2245032T3 (da) Folater, sammensætninger og anvendelser deraf
BRPI0906474A2 (pt) Certas entidades químicas, composições e métodos
ATE534660T1 (de) Peptidsequenzen und zusammensetzungen
DE602006006093D1 (de) Perfluorelastomerzusammensetzungen für tieftemperaturanwendungen
FR2899479B1 (fr) Composition cicatrisante
SMP200900058B (it) Composti e composizioni come inibitori di proteinachinasi.
DK2069352T3 (da) Bestemte kemiske enheder, sammensætninger og fremgangsmåder
BRPI0716881A2 (pt) Composições tópicas
BRPI0809573A8 (pt) composição, e, método
ATE442368T1 (de) 3-amino-2-arylpropylazaindole und anwendungen davon
BRPI0811430A2 (pt) Composições anti-insônia e processos
BRPI0719275A2 (pt) Composições de carbamatos de fenil-alquil-amino
BRPI0716458A2 (pt) Composição de vulcanizado
DE502007005744D1 (de) Schallgedämpftes, gasführendes Bauteil
BRPI0814167A2 (pt) Composição, e, método
ATE488514T1 (de) Piperidinverbindungen und anwendungen davon
DE502007001862D1 (de) Verdickungsmittel
BRPI0813922A2 (pt) composições de inibição de influenza e métodos.
BRPI0915560A2 (pt) composições e processos de fabricação de composições
DE602009000788D1 (de) Positive Resistzusammensetzungen und Strukturierungsverfahren
BRPI0814748A2 (pt) Compostos de alditóis substituídos, composições e métodos
BRPI0718141A2 (pt) Composições de frangrâncias
DE502006001779D1 (de) Allylorganopolysiloxane aufweisende vernetzbare zusammensetzungen